Product Information
HYDROMORPHONE HCL ER 8 MG TAB is a generic product labeled by Trigen Laboratories, LLC, priced at $5.8345 per EA under NDC 13811070110. Its NADAC has been published 293 times since Jan 11, 2017.
FDA first approved this application on Jul 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Hydromorphone Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
8 mg/1
Manufacturer
Trigen Laboratories, LLCNDC
13811070110
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205629FDA Approved
7/7/2016
TE Code
AB
On Market Since
9/15/2016
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE HCL ER 8 MG TAB has been published 293 times since Jan 11, 2017, and over the history we have for it it has declined 30.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.8345 per EA |
|---|---|
| All-time high | $9.1937 (Apr 12, 2017) |
| All-time low | $3.0250 (Mar 20, 2024) |
| 52-week high | $7.0165 |
| 52-week low | $5.8345 |
| Median price | $6.4546 |
| Average price | $6.1109 |
| Largest weekly change | -53.2% (Jun 21, 2023) |
| Weeks tracked | 293 |
| Tracking since | Jan 11, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROMORPHONE HCL ER 8 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 8 MG TAB, manufactured by Trigen Laboratories, LLC, is $5.8345 per EA (NDC 13811070110), effective Aug 19, 2026.
How has the price of HYDROMORPHONE HCL ER 8 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has declined 30.5%. It has been tracked across 293 weekly CMS publications since Jan 11, 2017.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 8 MG TAB?
Since Jan 11, 2017, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has ranged from a low of $3.0250 (Mar 20, 2024) to a high of $9.1937 (Apr 12, 2017), with a median of $6.4546 per EA.
Are there cheaper alternatives to HYDROMORPHONE HCL ER 8 MG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROMORPHONE 8 MG TABLET, is $0.5683 per EA — about 90% below HYDROMORPHONE HCL ER 8 MG TAB.
Who manufactures HYDROMORPHONE HCL ER 8 MG TAB?
HYDROMORPHONE HCL ER 8 MG TAB (NDC 13811070110) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.